• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM A. COOK AUSTRALIA, PTY LTD ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM A. COOK AUSTRALIA, PTY LTD ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ZFEN-P-2-28-109-R
Device Problems Material Separation (1562); Migration (4003)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 07/06/2022
Event Type  Injury  
Event Description
The proximal and distal main body's separated resulting in a total occlusion.Attempted to suck the clot out and bridge the separation.The bridging procedure was conducted, but the physician couldn't get all the clot out.
 
Manufacturer Narrative
No part of the device was returned for evaluation.No images were available for evaluation.The medical director reviewed the information supplied in the complaint as no imaging was received and confirmed the graft separation between the zfen-p and zfen-d.The separation was noted in (b)(6) 2022 and was not able to be bridged successfully.The medical director stated: "in most cases, the separation results in a large endoleak, leading to aneurysm expansion and often rupture, sometimes with the patient¿s death.In this case, the conduit thrombosed causing complete occlusion.Thrombectomy was performed, although they couldn¿t get all the clot out, and a re-lining bridging sleeve was used to bridge the gap between the zfen-p and the zfen-d.The usual cause of this problem is that the us-spec zfens have equal diameter for the distal zfen-p and the proximal zfen-d.In other words, it is a ¿slip fit¿ of the distal component into the proximal component.If the amount of overlap is inadequate as well, then separation is likely to occur over time, particularly in large aneurysms where the endograft can ¿bow¿ or arch forwards or sideways, in which case the distal component simply pulls out of the proximal component".Work order review could not be completed as the lot number is unknown.The instructions for use [ifu] supplied with the complaint device states: that the long-term performance of fenestrated endovascular grafts, including the stents placed in fenestrations/scallops, has not yet been established, and all patients should be advised that endovascular treatment requires life-long, regular follow-up to assess their health and the performance of their endovascular graft.Potential adverse events that may occur and/or require intervention include, but are not limited to: endoleak, component migration.Based on the information provided, the root cause could not be determined.It is possible that the separation was due to: inadequate diameter tolerance to ensure interference at overlap; inadequate separation force; inadequate length of overlap; patient-related factors.A capa was raised to address concerns of separation for the zfen-us devices.The capa determined "the conclusion of the investigation was that there is no fault/non-conformance of the us fen device, its labelling, its ifu, its manufacturing, nor its clinical use.The zfen us configuration meets the acceptance criteria for this product and the acceptance criteria are deemed acceptable.".
 
Event Description
The proximal and distal main body's separated resulting in a total occlusion.Attempted to suck the clot out and bridge the separation.The bridging procedure was conducted, but the physician couldn't get all the clot out.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY
Type of Device
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM A. COOK AUSTRALIA, PTY LTD
95 brandl street
eight mile plains
brisbane QLD 4 113
AS  QLD 4113
Manufacturer (Section G)
WILLIAM A. COOK AUSTRALIA, PTY LTD
95 brandl street
eight mile plains
brisbane QLD 4 113
AS   QLD 4113
Manufacturer Contact
meena harish
95 brandl street
eight mile plains
brisbane QLD 4-113
AS   QLD 4113
MDR Report Key15024236
MDR Text Key295952966
Report Number9680654-2022-00011
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZFEN-P-2-28-109-R
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/08/2022
Initial Date FDA Received07/14/2022
Supplement Dates Manufacturer Received07/07/2022
Supplement Dates FDA Received09/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexMale
-
-